Zhou J Y, Zhou S W. Effect of berberine on glucolipid metabolization in diabetic skeletal muscle and its mechanism[J].J Chin Pharmaceutical Sciences,2011,16(4):300-306.
[4]
Zhou J Y, Zhou S W. Effect of berberine on glucolipid metabolization in diabetic skeletal muscle and its mechanism[J].J Chin Pharmaceutical Sciences,2011,16(4):300-306.
Yin J, Xing H, Ye J. Efficacy of berberine in patients with type 2 diabetes mellitus[J].Metabolism,2008,57(5):712-717.
[7]
Yin J, Xing H, Ye J. Efficacy of berberine in patients with type 2 diabetes mellitus[J].Metabolism,2008,57(5):712-717.
[8]
李 真.生地黄连液对四氧嘧啶小鼠影响的研究[J].辽宁中医杂志,2000,27(12):574.
[8]
李 真.生地黄连液对四氧嘧啶小鼠影响的研究[J].辽宁中医杂志,2000,27(12):574.
[9]
陈其明,谢明智.黄连及黄连素降血糖作用的研究[J].药学学报,1986,21(6):401.
[9]
陈其明,谢明智.黄连及黄连素降血糖作用的研究[J].药学学报,1986,21(6):401.
[10]
Lee Y S, Kim W S, Kim K H, et al. Berberine, a natural plant product, activates AMP-activated protein kinase with beneficial metabolic effects in diabetic and insulin-resistant states[J].Diabetes,2012,55(8): 2256- 2264.
[10]
Lee Y S, Kim W S, Kim K H, et al. Berberine, a natural plant product, activates AMP-activated protein kinase with beneficial metabolic effects in diabetic and insulin-resistant states[J].Diabetes,2012,55(8): 2256- 2264.
[11]
Ko B S, Choi S B, Park S K, et al. Insulin sensitizing and insulinotropic action of berberine from Cortidis rhizome[J]. Biol Pharm Bull,2005,28:1431-1437.
[11]
Ko B S, Choi S B, Park S K, et al. Insulin sensitizing and insulinotropic action of berberine from Cortidis rhizome[J]. Biol Pharm Bull,2005,28:1431-1437.
[12]
Cheng Z, Pang T, Gu M, et al. Berberine-stimulated glucose uptake in L6 myotubes involves both AMPK and p38 MAPK[J]. Biochim Biophys Acta,2006,1760:1682-1689.
[12]
Cheng Z, Pang T, Gu M, et al. Berberine-stimulated glucose uptake in L6 myotubes involves both AMPK and p38 MAPK[J]. Biochim Biophys Acta,2006,1760:1682-1689.
[13]
Zhou L, Yang Y, Wang X, et al. Berberine stimulates glucose transport through a mechanism distinct from insulin[J]. Metabolism,2010,56:405-412.
[13]
Zhou L, Yang Y, Wang X, et al. Berberine stimulates glucose transport through a mechanism distinct from insulin[J]. Metabolism,2010,56:405-412.
[14]
Kim S H, Shin E J, Kim E D, et al. Berberine activates GLUT1-Mediated glucose uptake in 3T3-L1 adipocytes[J].Biol Pharm Bull,2007,30:2120-2125.
[14]
Kim S H, Shin E J, Kim E D, et al. Berberine activates GLUT1-Mediated glucose uptake in 3T3-L1 adipocytes[J].Biol Pharm Bull,2007,30:2120-2125.
[15]
Kong L D, Cheng C H, Tan R X. Monoamine oxidase inhibitors from rhizoma of Coptis chinensis[J]. Planta Med,2011,67:74-76.
[15]
Kong L D, Cheng C H, Tan R X. Monoamine oxidase inhibitors from rhizoma of Coptis chinensis[J]. Planta Med,2011,67:74-76.
[16]
Pospisilik J A, Knauf C, Joza N, et al.Targeted deletion of AIF decreases mitochondrial oxidative phosphorylation and protects from obesity and diabetes[J].Cell,2007,131:476-491.
[16]
Pospisilik J A, Knauf C, Joza N, et al.Targeted deletion of AIF decreases mitochondrial oxidative phosphorylation and protects from obesity and diabetes[J].Cell,2007,131:476-491.
[17]
Kong W, Wei J, Abidi P, et al. Berberine is a novel cholesterol -lowering drug working through a unique mechanism distinct from statins[J]. Nat Med,2012,10(12):1344-1351.
[17]
Kong W, Wei J, Abidi P, et al. Berberine is a novel cholesterol -lowering drug working through a unique mechanism distinct from statins[J]. Nat Med,2012,10(12):1344-1351.
[18]
Cicero A F, Rovati L C, Setnikar I. Eulipidemic effects of berberine administered alone or in combination with other natural cholesterol -lowering agents. A single-blind clinical investigation[J]. Arzneimittelforschung,2007,57:26-30.
[18]
Cicero A F, Rovati L C, Setnikar I. Eulipidemic effects of berberine administered alone or in combination with other natural cholesterol -lowering agents. A single-blind clinical investigation[J]. Arzneimittelforschung,2007,57:26-30.
[19]
Yin J, Chen M, Tang J,et al. Effects of berberine on glucose and lipid metabolism in animal experiment[J]. Chin J Diabetes,2004,12(3):215-218.
[19]
Yin J, Chen M, Tang J,et al. Effects of berberine on glucose and lipid metabolism in animal experiment[J]. Chin J Diabetes,2004,12(3):215-218.
[20]
Leng S H, Lu F E, Xu L J. Therapeutic effects of berberine in impaired glucose tolerance rats and its influence on insulin secretion[J]. Acta Pharmacol Sin,2004,25(4):496-502.
[21]
勾祥辉.黄连素治疗高血脂59例[J].人民军医,2008,2(1):35.
[20]
Leng S H, Lu F E, Xu L J. Therapeutic effects of berberine in impaired glucose tolerance rats and its influence on insulin secretion[J]. Acta Pharmacol Sin,2004,25(4):496-502.
Rosen E D, MacDougald O A. Adipocyte differentiation from the inside out[J].Nat Rev Mol Cell Biol,2006,7(12):885-896.
[24]
Rosen E D, MacDougald O A. Adipocyte differentiation from the inside out[J].Nat Rev Mol Cell Biol,2006,7(12):885-896.
[25]
Abidi P, Zhou Y, Jiang JD,et al.Extracellular signal-regulated kinase-dependent stabilization of hepatic low-density lipoprotein receptor mRNA by herbal medicine berberine[J]. Arterioscler Thromb Vasc Biol,2005,25(10):2170-2176.
[25]
Abidi P, Zhou Y, Jiang JD,et al.Extracellular signal-regulated kinase-dependent stabilization of hepatic low-density lipoprotein receptor mRNA by herbal medicine berberine[J]. Arterioscler Thromb Vasc Biol,2005,25(10):2170-2176.
[26]
Lee S, Lim H J, Park H Y,et al.Berberine inhibits rat vascular smooth muscle cell proliferation and migration in vitro and improves neointima formation after balloon injury in vivo[J]. Atherosclerosis,2006,186(1):s29-37.
[26]
Lee S, Lim H J, Park H Y,et al.Berberine inhibits rat vascular smooth muscle cell proliferation and migration in vitro and improves neointima formation after balloon injury in vivo[J]. Atherosclerosis,2006,186(1):s29-37.
[27]
Liang K W, Ting C T, Yin S C, et al. Berberine suppresses MEK/ERKdependent Egr-1 signaling pathway and inhibits vascular smooth muscle cell regrowth after in vitro mechanical injury[J].Biochem Pharmacol,2006,71(6):806-817.
[27]
Liang K W, Ting C T, Yin S C, et al. Berberine suppresses MEK/ERKdependent Egr-1 signaling pathway and inhibits vascular smooth muscle cell regrowth after in vitro mechanical injury[J].Biochem Pharmacol,2006,71(6):806-817.
[28]
Lee S, Lim H J, Park J H,et al. Berberine-induced LDLR up-regulation involves JNK pathway[J].Biochem Biophys Res Commun,2007,362(4):853-857.
[28]
Lee S, Lim H J, Park J H,et al. Berberine-induced LDLR up-regulation involves JNK pathway[J].Biochem Biophys Res Commun,2007,362(4):853-857.
[29]
Zhou J Y, Zhou S W. Effect of berberine on glucolipid metabolization in diabetic skeletal muscle and its mechanism[J]. J Chin Pharmaceutical Sciences,2011,16(4):300-306.
[29]
Zhou J Y, Zhou S W. Effect of berberine on glucolipid metabolization in diabetic skeletal muscle and its mechanism[J]. J Chin Pharmaceutical Sciences,2011,16(4):300-306.
[30]
Choi B H, Ahn I S, Kim Y H, et al. Berberine reduces the expression of adipogenic enzymes and inflammatory molecules of 3T3-L1 adipocyte[J]. Exp Mol Med,2012,38(6):599-605.
[30]
Choi B H, Ahn I S, Kim Y H, et al. Berberine reduces the expression of adipogenic enzymes and inflammatory molecules of 3T3-L1 adipocyte[J]. Exp Mol Med,2012,38(6):599-605.
2014, Vol. 25 
